VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL DATA OF TQ-A3334 "TLR7 AGONIST" PRESENTED AT THE 2026 AASLD
01177 Sino Biopharmaceutical Ltd.SBP GROUPHong Kong Stock Exchange
11 posts
Sino Biopharmaceutical Ltd. (01177) at a glance
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Sino Biopharmaceutical Ltd. (01177) Stock Price History
Sino Biopharmaceutical Ltd. closed at HK$5.54 on Nov 11, 2026, +2.3% over 1 month, −19.4% over 1 year.
If you had invested HK$10,000 1 month ago, it would be worth HK$10,250 today (+2.5%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +0.2%, while this stock moved +2.5%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 11 (Wed) | HK$5.54 | −0.02 | −0.36% |
| Nov 10 (Tue) | HK$5.56 | +0.09 | +1.55% |
| Nov 9 (Mon) | HK$5.47 | −0.13 | −2.32% |
| Nov 6 (Fri) | HK$5.60 | −0.03 | −0.44% |
| Nov 5 (Thu) | HK$5.63 | +0.48 | +9.22% |
| Nov 4 (Wed) | HK$5.15 | +0.27 | +5.42% |
| Nov 3 (Tue) | HK$4.89 | +0.02 | +0.41% |
| Nov 2 (Mon) | HK$4.87 | +0.04 | +0.93% |
| Oct 30 (Fri) | HK$4.82 | −0.03 | −0.62% |
| Oct 29 (Thu) | HK$4.85 | −0.01 | −0.10% |
If you had invested HK$10,000 3 months ago, it would be worth HK$11,070 today (+10.7%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −5.2%, while this stock moved +10.7%.
Last 10 Trading Days
| Date | Close | Change | % Change |
|---|---|---|---|
| Nov 11 (Wed) | HK$5.54 | −0.02 | −0.36% |
| Nov 10 (Tue) | HK$5.56 | +0.09 | +1.55% |
| Nov 9 (Mon) | HK$5.47 | −0.13 | −2.32% |
| Nov 6 (Fri) | HK$5.60 | −0.03 | −0.44% |
| Nov 5 (Thu) | HK$5.63 | +0.48 | +9.22% |
| Nov 4 (Wed) | HK$5.15 | +0.27 | +5.42% |
| Nov 3 (Tue) | HK$4.89 | +0.02 | +0.41% |
| Nov 2 (Mon) | HK$4.87 | +0.04 | +0.93% |
| Oct 30 (Fri) | HK$4.82 | −0.03 | −0.62% |
| Oct 29 (Thu) | HK$4.85 | −0.01 | −0.10% |
If you had invested HK$10,000 6 months ago, it would be worth HK$9,779 today (−2.2%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.9%, while this stock moved −2.2%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | HK$5.54 | +14.8% |
| Oct 2026 | HK$4.82 | −15.6% |
| Sep 2026 | HK$5.71 | +4.8% |
| Aug 2026 | HK$5.45 | +8.3% |
| Jul 2026 | HK$5.03 | +14.1% |
| Jun 2026 | HK$4.41 | −11.6% |
| May 2026 | HK$4.99 | −7.9% |
If you had invested HK$10,000 1 year ago, it would be worth HK$8,057 today (−19.4%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −8.9%, while this stock moved −19.4%.
Monthly Closes
| Month | Month-End Close | Monthly % |
|---|---|---|
| Nov 2026 | HK$5.54 | +14.8% |
| Oct 2026 | HK$4.82 | −15.6% |
| Sep 2026 | HK$5.71 | +4.8% |
| Aug 2026 | HK$5.45 | +8.3% |
| Jul 2026 | HK$5.03 | +14.1% |
| Jun 2026 | HK$4.41 | −11.6% |
| May 2026 | HK$4.99 | −7.9% |
| Apr 2026 | HK$5.42 | −8.0% |
| Mar 2026 | HK$5.89 | −2.6% |
| Feb 2026 | HK$6.05 | −8.9% |
| Jan 2026 | HK$6.64 | +7.4% |
| Dec 2025 | HK$6.18 | −12.3% |
| Nov 2025 | HK$7.05 | −0.3% |
If you had invested HK$10,000 3 years ago, it would be worth HK$14,452 today (+44.5%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +39.3%, while this stock moved +44.5%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$5.54 | −10.4% |
| 2025 | HK$6.18 | ― |
If you had invested HK$10,000 5 years ago, it would be worth HK$9,543 today (−4.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −2.9%, while this stock moved −4.6%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$5.54 | −10.4% |
| 2025 | HK$6.18 | ― |
If you had invested HK$10,000 in Jun 2004, it would be worth HK$588,830 today (+5,788.3%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +89.2%, while this stock moved +5,788.3%.
Yearly Closes
| Year | Year-End Close | Yearly % |
|---|---|---|
| 2026 (YTD) | HK$5.54 | −10.4% |
| 2025 | HK$6.18 | +91.9% |
| 2024 | HK$3.22 | −7.2% |
| 2023 | HK$3.47 | −24.1% |
| 2022 | HK$4.57 | −16.3% |
| 2021 | HK$5.46 | −27.7% |
| 2020 | HK$7.55 | +3.9% |
| 2019 | HK$7.27 | +111.3% |
| 2018 | HK$3.44 | −44.2% |
| 2017 | HK$6.16 | +153.8% |
| 2016 | HK$2.43 | −22.7% |
| 2015 | HK$3.14 | +50.6% |
| 2014 | HK$2.08 | +14.3% |
| 2013 | HK$1.82 | +66.2% |
| 2012 | HK$1.10 | +60.2% |
| 2011 | HK$0.68 | −20.1% |
| 2010 | HK$0.86 | +15.5% |
| 2009 | HK$0.74 | +375.0% |
| 2008 | HK$0.16 | −27.4% |
| 2007 | HK$0.22 | +58.1% |
| 2006 | HK$0.14 | −42.4% |
| 2005 | HK$0.24 | +51.3% |
| 2004 | HK$0.16 | ― |
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Jun 2004). Please check the latest prices before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
VOLUNTARY ANNOUNCEMENT - PHASE II CLINICAL DATA OF TQ-A3334 "TLR7 AGONIST" PRESENTED AT THE 2026 AASLD
VOLUNTARY ANNOUNCEMENT - ENTER INTO PARTNERSHIP WITH BOEHRINGER INGELHEIM WITH POTENTIAL TOTAL DEAL VALUE OF US$7 BILLION
Delete
VOLUNTARY ANNOUNCEMENT - TQ-A3334 "TLR7 AGONIST" AND TQA3605 "CORE PROTEIN ALLOSTERIC MODULATOR" GRANTED BREAKTHROUGH THERAPY DESIGNATION BY CDE
Delete
VOLUNTARY ANNOUNCEMENT - DATA FROM TWO CLINICAL STUDIES OF TQB2102 "HER2 BIPARATOPIC ADC" PRESENTED AT 2026 ESMO
Delete
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL PARTICIPANTS ENROLLMENT IN THE PHASE III REGISTRATIONAL CLINICAL TRIAL OF TQC2731 INJECTION "TSLP MONOCLONAL ANTIBODY" FOR CHRONIC SINUSITIS WITH NASAL POLYPS
Delete
VOLUNTARY ANNOUNCEMENT - LATEST RESEARCH RESULTS ON TQ-A3334 "TLR7 AGONIST" AND BEPIROVIRSEN "ASO" TO BE PRESENTED AT 2026 AASLD
Delete
VOLUNTARY ANNOUNCEMENT - COMPLETION OF ALL SUBJECTS ENROLLMENT IN THE PHASE III REGISTRATIONAL CLINICAL TRIAL OF TQC3721 INHALATION SUSPENSION "PDE3/4 INHIBITOR"
Delete
VOLUNTARY ANNOUNCEMENT - ENTER INTO STRATEGIC BIOSIMILARS PARTNERSHIP WITH STADA
Delete
2026 INTERIM REPORT
Delete
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQH2722 INJECTION
Delete
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF NEW DRUG APPLICATION FOR TQB2102 INJECTION "HER2 BISPECIFIC ADC"
Delete
Write on the Sino Biopharmaceutical Ltd. board
More Chinese stocks in English
- H World Group Limited01179
- Paradise Entertainment Limited01180
- TANG PALACE (CHINA) HOLDINGS LIMITED01181
- Success Dragon International Holdings Limited01182
- MECOM Power and Construction Limited01183
- S.A.S. Dragon Holdings Ltd.01184
- China Railway Construction Corporation Limited01186
- Cofoe Medical Technology Co.,Ltd.01187
- Hybrid Kinetic Group Limited01188
- Crealights Technology Co., Ltd.01191
- China Resources Gas Group Limited01193
- Kingwell Group Limited01195